bankruptcy

Drowning in litigation, Mallinckrodt becomes third opioid producer to file for bankruptcy
Drowning in litigation, Mallinckrodt becomes third opioid producer to file for bankruptcy
Endpoints
Mallinckrodt
opioid crisis
opioids
bankruptcy
Flag link:
Court approves Otsuka’s bid to buy Proteus for $15M
Court approves Otsuka’s bid to buy Proteus for $15M
MedCity News
M&A
Otsuka
Proteus Digital Health
bankruptcy
patient adherence
Flag link:
Mallinckrodt considering bankruptcy
Mallinckrodt considering bankruptcy
Beckers Hospital Review
Mallinckrodt
bankruptcy
opioids
opioid crisis
Flag link:
Endologix Initiates Chapter 11 and is Set to Go Private
Endologix Initiates Chapter 11 and is Set to Go Private
Medical Devices and Diagnostics Industry
Endologix
bankruptcy
Chapter 11
devices
Flag link:
6 pharmaceutical, devicemaker bankruptcies in 2020
6 pharmaceutical, devicemaker bankruptcies in 2020
Beckers Hospital Review
bankruptcy
devices
pharma industry
KRS Global
Insys
Valeritas
Reva Medical
Akorn
Mallinckrodt
Flag link:
Proteus files for bankruptcy: Where did it falter?
Proteus files for bankruptcy: Where did it falter?
MedCity News
Proteus Digital Health
Otsuka
smart pills
bankruptcy
Flag link:
Generic drugmaker Akorn files for bankruptcy
Generic drugmaker Akorn files for bankruptcy
Beckers Hospital Review
Akorn
generics
bankruptcy
Flag link:
Melinta's Bankruptcy Underlines Problems with the Antibiotics Market
Melinta's Bankruptcy Underlines Problems with the Antibiotics Market
BioSpace
Melinta Therapeutics
bankruptcy
antibiotics
Flag link:
Melinta’s Chapter 11 Auction Draws No Bids, Deerfield to Get Asset
Melinta’s Chapter 11 Auction Draws No Bids, Deerfield to Get Asset
Xconomy
Melinta Therapeutics
Chapter 11
bankruptcy
Flag link:
Mallinckrodt floats $1.6B opioid deal, bankruptcy for specialty generics unit
Mallinckrodt floats $1.6B opioid deal, bankruptcy for specialty generics unit
Fierce Pharma
Mallinckrodt
opioids
bankruptcy
Flag link:
Melinta seeks buyout bids to secure escape from bankruptcy
Melinta seeks buyout bids to secure escape from bankruptcy
Fierce Biotech
Melinta Therapeutics
M&A
bankruptcy
Flag link:
Biotech was big in 2019, but here's one record no one wanted to see broken: Most bankruptcies
Biotech was big in 2019, but here's one record no one wanted to see broken: Most bankruptcies
Endpoints
biotech
bankruptcy
Flag link:
Insys bankruptcy plan gets court OK
Insys bankruptcy plan gets court OK
Beckers Hospital Review
INSYS Therapeutics
bankruptcy
opioids
Flag link:
Bioresorbable scaffolds flounder as Reva heads to bankruptcy
Bioresorbable scaffolds flounder as Reva heads to bankruptcy
EP Vantage
devices
bioresorbable vascular scaffold
Abbott Labs
Amaranth
Reva Medical
bankruptcy
Flag link:
Antibiotics maker Melinta files for Chapter 11 bankruptcy
Antibiotics maker Melinta files for Chapter 11 bankruptcy
Reuters
Melinta Therapeutics
Chapter 11
bankruptcy
antibiotics
Flag link:
Audit: Sackler family took $10B from Purdue Pharma amid opioid suits
Audit: Sackler family took $10B from Purdue Pharma amid opioid suits
UPI
Purdue Pharma
Sackler family
oxycontin
bankruptcy
opioids
opioid crisis
Flag link:
Bankrupt Insys offers to turn out its almost empty pockets for plaintiffs
Bankrupt Insys offers to turn out its almost empty pockets for plaintiffs
Fierce Pharma
Insys
bankruptcy
SEC
DOJ
Flag link:
Purdue to Pay States’ Legal Fees to Expedite Release of Emergency Funds
Purdue to Pay States’ Legal Fees to Expedite Release of Emergency Funds
Fierce Pharma
Purdue Pharma
bankruptcy
opioids
opioid crisis
Flag link:
The 11 biopharma companies that declared bankruptcy this year
The 11 biopharma companies that declared bankruptcy this year
Biopharma Dive
bankruptcy
Purdue Pharma
Achaogen
Pernix Therapeutics
Flag link:
31 biopharmas at high risk of bankruptcy in 2020
31 biopharmas at high risk of bankruptcy in 2020
Biopharma Dive
bankruptcy
Teva Pharmaceutical
Bausch Health
Novavax
Flag link:

Pages